Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there is a specialized molecule on the surface of cells termed MR1. MR1 allows sensing of certain small molecule metabolites derived from cellular and microbial sources; however, the breadth of metabolite sensing is unclear. Researchers have identified a form of vitamin B6 bound to MR1 as a means of engaging tumor-reactive immune cells.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Left or right arm? New research reveals why vaccination site matters for immune response
- Are 'zombie' skin cells harmful or helpful? The answer may be in their shapes
- New way to prevent duodenal cancer
- Immune cells drive congenital paralysis disease
- Scientists develop new bone marrow imaging technique
- Blocking a surprising master regulator of immunity eradicates liver tumors in mice
- New bioactive compound for difficult-to-treat allergies
- Clinical trials to test vaccine against Alzheimer's-promoting tau protein
- B cells found to be crucial for long-term vaccine protection, new study shows
- Post-treatment Lyme disease syndrome may be driven by remnants of infection
